| Specific “Ramadan-focused education” is associated with better outcomes and less complications. |
5 |
19 |
| Patients with type 1 diabetes are not exempt from fasting and should not refrain from fasting. |
7 |
26 |
| Most hypoglycemic episodes occur during the last 2-3 hours of the fast. |
24 |
96 |
| Pregnant diabetic women should be advised to avoid observing the fast. |
27 |
100 |
| DDP-IV inhibitors have been shown to lead to less hypoglycemic episodes than sulphonylureas in general. |
12 |
44 |
| All sulphonylureas carry the same hypoglycemic risk potential. |
23 |
85 |
| SGLT2 inhibitors need to be used carefully in elderly patients and those with increased risk of dehydration. |
0 |
00 |
| “LIRA-Ramadan Study” concluded that GLP-1 therapy should never be used during Ramadan fasting. |
6 |
22 |
| If a patient who is observing the fast on insulin develops confirmed hypoglycemia, he should break the fast immediately. |
19 |
70 |
| Premixed insulin dose should be inverted with higher doses before Iftar (sunset meal) and reduced doses before Suhor (dawn meal). |
14 |
52 |
| It is prudent to reduce the doses of basal insulin to avoid day time hypoglycemia. |
3 |
11 |
| Patients on any type of insulin should not monitor their blood glucose during the day time as blood testing breaks the fast. |
4 |
15 |
